United Nations DoEaSA. Leaving no one behind in an ageing world - World Social Report 2023.

Postmus I, Deelen J, Sedaghat S, Trompet S, de Craen AJ, Heijmans BT, et al. LDL cholesterol still a problem in old age? A Mendelian randomization study. Int J Epidemiol. 2015;44(2):604–12.

Article  PubMed  Google Scholar 

Mortensen MB, Falk E. Primary prevention with statins in the elderly. J Am Coll Cardiol. 2018;71(1):85–94.

Article  PubMed  Google Scholar 

Members ATF, (CPG) ECfPG, Societies ENC. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140-205.

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(24):e285–350.

Article  PubMed  Google Scholar 

Zhou Z, Tonkin AM, Curtis AJ, Murray A, Zhu C, Reid CM, et al. Low-density-lipoprotein cholesterol and mortality outcomes among healthy older adults: a post hoc analysis of ASPREE trial. J Gerontol A Biol Sci Med Sci. 2024;79(4):glad268. https://doi.org/10.1093/gerona/glad268

Ruscica M, Macchi C, Pavanello C, Corsini A, Sahebkar A, Sirtori CR. Appropriateness of statin prescription in the elderly. Eur J Intern Med. 2018;50:33–40.

Article  CAS  PubMed  Google Scholar 

Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010;152(8):488–96 (W174).

Article  PubMed  PubMed Central  Google Scholar 

Ray KK, Bach RG, Cannon CP, Cairns R, Kirtane AJ, Wiviott SD, et al. Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS. Eur Heart J. 2006;27(19):2310–6.

Article  CAS  PubMed  Google Scholar 

Savarese G, Gotto AM, Paolillo S, D’Amore C, Losco T, Musella F, et al. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol. 2013;62(22):2090–9.

Article  CAS  PubMed  Google Scholar 

Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–81.

Article  CAS  PubMed  Google Scholar 

Morton JI, Marquina C, Lloyd M, Watts GF, Zoungas S, Liew D, et al. Lipid-lowering strategies for primary prevention of coronary heart disease in the UK: a cost-effectiveness analysis. Pharmacoeconomics. 2024;42(1):91–107.

Article  PubMed  Google Scholar 

Mihaylova B, Wu R, Zhou J, Williams C, Schlackow I, Emberson J, et al. Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study. Heart. 2024;110(21):1277–85.

Article  PubMed  Google Scholar 

Guthrie B, Rogers G, Livingstone S, Morales DR, Donnan P, Davis S, et al. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis. Health Soc Care Deliv Res. 2024;12(4):1–275.

PubMed  Google Scholar 

Cheung BM, Lauder IJ, Lau CP, Kumana CR. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol. 2004;57(5):640–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–207.

Article  CAS  PubMed  Google Scholar 

Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial–lipid lowering arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361(9364):1149–58.

Article  CAS  PubMed  Google Scholar 

Cobos-Palacios L, Sanz-Cánovas J, Muñoz-Ubeda M, Lopez-Carmona MD, Perez-Belmonte LM, Lopez-Sampalo A, et al. Statin therapy in very old patients: lights and shadows. Front Cardiovasc Med. 2021;8: 779044.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collaboration CTT. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393(10170):407–15.

Article  Google Scholar 

Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, et al. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020;396(10263):1637–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hemann BA, Bimson WF, Taylor AJ. The Framingham Risk Score: an appraisal of its benefits and limitations. Am Heart Hosp J. 2007;5(2):91–6.

Article  PubMed  Google Scholar 

ASCVD Risk Estimator Plus. [cited 2024 September, 2024]. https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/. Accessed 30 Sept 2024.

Dalton JE, Rothberg MB, Dawson NV, Krieger NI, Zidar DA, Perzynski AT. Failure of traditional risk factors to adequately predict cardiovascular events in older populations. J Am Geriatr Soc. 2020;68(4):754–61.

Article  PubMed  PubMed Central  Google Scholar 

Collaboration S-OwgaECr. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455-67.

Hui G, Koch B, Calara F, Wong ND. Angina in coronary artery disease patients with and without diabetes: US national health and nutrition examination survey 2001–2010. Clin Cardiol. 2016;39(1):30–6.

Article  PubMed  Google Scholar 

Buford TW. Hypertension and aging. Ageing Res Rev. 2016;26:96–111.

Article  PubMed  PubMed Central  Google Scholar 

Wenger NK, Froelicher ES, Smith LK, Ades PA, Berra K, Blumenthal JA, et al. Cardiac rehabilitation as secondary prevention Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute. Clin Pract Guidel Quick Ref Guide Clin. 1995;17:1–23.

Google Scholar 

Afilalo J, Duque G, Steele R, Jukema JW, de Craen AJ, Eisenberg MJ. Statins for secondary prevention in elderly patients: a hierarchical Bayesian meta-analysis. J Am Coll Cardiol. 2008;51(1):37–45.

Article  CAS  PubMed  Google Scholar 

Foody JM, Roe MT, Chen AY, Smith SC, Brindis RG, Peterson ED, et al. Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE). Am J Cardiol. 2005;95(4):483–5.

Article  PubMed  Google Scholar 

Harder S, Fischer P, Krause-Schäfer M, Ostermann K, Helms G, Prinz H, et al. Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany. Eur J Clin Pharmacol. 2005;60(11):797–805.

Article  PubMed  Google Scholar 

Philippe F, Danchin N, Quentzel S, Cambou JP. Utilization of the principle therapeutic classes for cardiovascular prevention in elderly patients seen by cardiologists. The ELIAGE survey. Ann Cardiol Angeiol (Paris). 2004;53(6):339–46.

Article  CAS  PubMed  Google Scholar 

Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, et al. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997–2000. Can J Cardiol. 2004;20(1):61–7.

PubMed  Google Scholar 

Vicent L, Ariza-Solé A, Díez-Villanueva P, Alegre O, Sanchís J, López-Palop R, et al. Statin treatment and prognosis of elderly patients discharged after non-st segment elevation acute coronary syndrome. Cardiology. 2019;143(1):14–21.

Article  CAS  PubMed  Google Scholar 

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019;139(25):e1082–143.

PubMed  Google Scholar 

Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, et al. 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Can J Cardiol. 2021;37(8):1129–50.

Article  PubMed  Google Scholar 

Singh M, McEvoy JW, Khan SU, Wood DA, Graham IM, Blumenthal RS, et al. Comparison of transatlantic approaches to lipid management: the AHA/ACC/Multisociety guidelines vs the ESC/EAS guidelines. Mayo Clin Proc. 2020;95(5):998–1014.

Article